Skip to main content
Reckitt Benckiser Group PLC logo

Reckitt Benckiser Group PLC — Investor Relations & Filings

Ticker · RKT ISIN · GB00B24CGK77 LEI · 5493003JFSMOJG48V108 IL Manufacturing
Open in API
Filings indexed 1,840 across all filing types
Latest filing 2023-05-03 AGM Information
Country GB United Kingdom
Listing IL RKT

About Reckitt Benckiser Group PLC

https://www.reckitt.com/

Reckitt Benckiser Group PLC is a global manufacturer of consumer products in the health, hygiene, and nutrition sectors. The company's mission is to protect, heal, and nurture in the pursuit of a cleaner, healthier world. It operates a portfolio of trusted brands, many of which hold market-leading positions in their categories. Key brands include Lysol, Dettol, Durex, Mucinex, Nurofen, Strepsils, Gaviscon, Finish, and Vanish. Leveraging scientific expertise and consumer insights, the company develops and distributes products designed to improve the daily lives of consumers worldwide, with over 30 million of its products sold daily.

Recent filings

Filing Released Lang Actions
AGM Special Business
AGM Information Classification · 99% confidence The document explicitly states it contains the 'RESOLUTIONS OF RECKITT BENCKISER GROUP PLC' passed at the 'Annual General Meeting of the Company held at... on Wednesday 3 May 2023'. It details the specific resolutions passed (Ordinary and Special), covering topics like political donations, authority to allot shares, disapplication of pre-emption rights, and purchase of own shares. This content is the official record of the business conducted and the outcomes decided at the AGM. Therefore, it fits the definition of AGM Information (AGM-R).
2023-05-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal notification identified by the 'RNS Number' and explicitly states it is provided by RNS, the news service of the London Stock Exchange. The content details the total number of issued shares, treasury shares, and the resulting total voting rights as of a specific date (30 April 2023), referencing the Disclosure Guidance and Transparency Rules (DTR 5.6.1). This type of announcement, which communicates a change or status related to voting rights and capital structure, aligns most closely with the definition of a general regulatory announcement or a specific filing related to voting rights. Since there is no specific code for 'Voting Rights Update', and it is a standard regulatory disclosure via RNS, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a declaration of voting results (DVA) but rather the denominator used for future calculations. Given the context of RNS distribution and the nature of the information (capital/voting rights disclosure), RNS is the most appropriate general classification.
2023-05-02 English
New CEO Announcement
Board/Management Information Classification · 100% confidence The document is clearly identified as an RNS announcement by the header "RNS Number : 4443X" and the closing statement referencing RNS as the news service of the London Stock Exchange, approved by the FCA. The content announces a significant change in senior management: the appointment of Kris Licht as CEO Designate, succeeding Nicandro Durante. This directly matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the core subject matter is management change, making MANG the most specific classification. The document also contains remuneration details (Appendix 1), which might suggest DEF 14A, but the primary focus and headline are the CEO appointment.
2023-04-26 English
Q1 Trading Statement
Earnings Release Classification · 98% confidence The document is a regulatory filing announcement, indicated by the 'RNS Number' and the date stamp '26 April 2023'. The content provides key financial highlights for 'Q1 2023' (Total net revenue £3,917m, LFL growth +7.9%), management commentary, outlook updates, and conference call details. This structure—a summary announcement of recent period results—is characteristic of an Earnings Release (ER). It is not the full, comprehensive report (which would be an IR or 10-K), nor is it just a transcript (CT) or a proxy statement (PSI). Since it contains the initial, summarized financial results for a period, ER is the most appropriate classification. Q1 2023
2023-04-26 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal notification identified by the 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the total issued ordinary shares, treasury shares, and the resulting 'total voting rights' as of a specific date (31 March 2023), referencing the Disclosure Guidance and Transparency Rules (DTR 5.6.1). This type of mandatory disclosure regarding the total number of shares and voting rights, often used as the denominator for shareholder notifications, is a standard regulatory announcement. Since it is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Dividend Notice (DIV), the most appropriate classification is the general regulatory filing category, RNS.
2023-04-03 English
Annual Financial Report 2022-T01
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-03-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.